Human fibrillin-1 is the major structural protein of extracellular matrix 10-12 nm microfibrils. It has a disulfide-rich modular organization which consists primarily of cbEGF (Ca 2+ -binding epidermal growth factor-like) domains and TB (transforming growth factor β-binding protein-like) domains. TB4 contains an RGD (Arg-Gly-Asp) integrin-binding motif. The atomic structure of this region has been solved by X-ray crystallography and shows the TB4 and flanking cbEGF domains to be arranged as a tetragonal pyramid with N-and C-termini exposed at opposite ends of the fragment. The RGD integrin-binding motif is located within a flexible loop. We have used a variety of biophysical, biochemical and cell biology methods to investigate the molecular properties of integrin-fibrillin-1 interactions and have demonstrated that recombinant fibrillin-1 domain fragments mediate binding to integrins αVβ3, α5β1 and αVβ6. Integrin αVβ3 is a high-affinity fibrillin-1 receptor (K d ∼ 40 nM), whereas integrins αVβ6 and α5β1 show moderate-affinity (K d ∼ 450 nM) and low-affinity (K d > 1 μM) binding respectively. Different patterns of α5β1 distribution are seen when human keratinocytes and fibroblasts are plated on to fibrillin domain fragments compared with those seen for fibronectin, suggesting that fibrillin may cause a lesser degree or different type of intracellular signalling. A number of disease-causing mutations which affect the TB4 domain have been identified. These are being investigated for their effects on integrin binding and/or changes in intramolecular structure.
Fibrillin-1 and Marfan syndrome
Human fibrillin-1 is a 350 kDa extracellular matrix glycoprotein [1] . It assembles to form large macromolecular 10-12 nm microfibrils which confer tensile strength to connective tissues, contribute to cell-matrix interactions and act as a store of cytokines via their interactions with the LTBPs (latent transforming growth factor β-binding proteins) [2] . Mutations in FBN1, the gene encoding fibrillin-1, cause Marfan syndrome and related disorders [3, 4] . This connective tissue disease affects the ocular, cardiovascular and skeletal systems of the body. The major morbidity and mortality associated with the disease is due to aortic dilatation and dissection which occur as a result of a loss of functional microfibrils in the aortic wall. Since missense, nonsense and splice-site mutations have all been identified in cases of Marfan syndrome [5, 6] , it is likely that both a reduction in number of microfibrils as well as changes to the structure of microfibrils underlie the pleiotropic manifestations of the disease.
Structure of fibrillin and microfibrils
The modular architecture of fibrillin-1 is made up mainly of EGF (epidermal growth factor)-like and TB (transforming growth factor β-binding protein-like) domains (Figure 1 ), although, in addition to these domains, there are two hybrid domains, a proline-rich region and N-and Cterminal regions. Many of the fibrillin-1 EGF-like domains occur as multiple tandem repeats, most of which contain a Ca 2+ -binding consensus sequence and are known as cbEGF (Ca 2+ -binding EGF-like) domains [7] . These are widely distributed among other extracellular and cell-surface proteins. A variety of biophysical and biochemical techniques have been used to study Ca 2+ binding to these domains, and Ca 2+ has been demonstrated to bind to all fibrillin-1 cbEGF domains studied so far [8] [9] [10] [11] . Structural and dynamic studies of tandem repeats of cbEGF domains have demonstrated that Ca 2+ confers structural rigidity to the fragment, producing a rod-like conformation [12] [13] [14] [15] . This effect can be attributed to the location of the metal-ion-binding site in the N-terminal part of the domain, thus positioning it in the interdomain region of a tandem pair, and to the presence of a conserved hydrophobic packing interaction between the two domains. Unlike the EGF-like domain, the TB module is found only in the fibrillin/LTBP family of proteins which is confined to the extracellular matrix. A previous NMR study demonstrated that fibrillin-1 TB6 adopted a globular fold stabilized by a hydrophobic core and four intradomain disulfide bonds [16] . The availability of atomic structures for both the TB The fibrillin sequence is dominated by 47 EGF-like domains, of which 43 are of the Ca 2+ -binding type (cbEGF), interspersed with TB domains.
Other domains include unique N-and C-termini, a proline-rich region that may act as a flexible hinge, and two 'hybrid' domains that have properties of both the TB and cbEGF domains. The position of the integrin-binding RGD motif (*) is indicated.
domain and cbEGF pairs has enabled modelling of larger regions of fibrillin to be performed [17] . Rotary shadowing EM (electron microscopy) has demonstrated that extracted microfibrils have a 56 nm bead-bead periodicity and a Ca 2+ -dependent ultrastructure [18] [19] [20] . Collectively, these data, coupled with the knowledge that monoclonal antibodies against fibrillin-1 labelled microfibrils periodically [14, 21] , led to the proposal that fibrillin formed an extended structure across two beads, which with a 50% overlap would generate the observed 56 nm periodicity [12] . At the same time, another model based predominantly on EM images and mass mapping was proposed which suggested that fibrillin adopted a folded-back structure and spanned a single bead [22] . More recently, a model has been proposed based on small-angle X-ray scattering and multiangle laser-light-scattering data of overlapping fibrillin fragments spanning from domains TB1 to the C-terminus [23] . In this model, each fibrillin monomer is compacted so that it spans a single interbead distance, with the TB4 domain positioned near a bead (Figure 2 ). Bends are proposed to form in the region of the second hybrid domain and at the junctions of some cbEGF domain pairs, possibly as a result of N-linked glycosylation. High-resolution structural studies on glycosylated cbEGF domain pairs and hybrid domains are required to confirm this model.
Atomic structure of RGD (Arg-Gly-Asp)-containing cbEGF22-TB4-cbEGF23
A limitation of the microfibril model based on atomic structures of TB and cbEGF domains was the absence of structures for the pairwise interactions of TB-cbEGF and cbEGF-TB domains. This was addressed by an analysis of the cbEGF22-TB4-cbEGF23 fragment which contained an RGD integrinbinding motif [17] . Crystal structures of this region demonstrated that it formed a Ca 2+ -rigidified tetragonal pyramid, with N-and C-termini extending from opposite ends of the fragment (Figure 3 ). This study also identified the location of the RGD motif on a flexible loop at the tip of a conserved β-hairpin, as predicted by a previous NMR study [16] and consistent with the integrin-binding properties of recombinant fragments encompassing this region [24, 25] . Analysis of the Ca 2+ -binding sites within the fragment demonstrated In the first, fibrillin monomers are folded at defined regions so that each monomer is contained within a single interbead distance [23] . (b) In other models, fibrillin monomers exist as extended structures spanning two [12, 33] or, in some models, three [17] interbead distances. All current models agree on the fibrillin Nand C-termini being in or very close to the bead; however, the exact composition of the bead structures observed by rotary shadowing EM is still unclear. the expected pentagonal bi-pyramidal geometry, with seven intramolecular ligands. On the basis of this study, it was possible to refine further the extended model of microfibril organization using the new information about the cbEGF-TB and TB-cbEGF interfaces and the location of the RGD site within TB4, and propose that the basis of some bead-to-bead variation seen in microfibril images was due to an internal molecular spring identified at the TB4-cbEGF23 interface [17] .
Ca

2+ -dependent interfaces
Early experiments on fibrillin cbEGF domains demonstrated that N-terminal linkage of a cbEGF domain raised the affinity of the C-terminal cbEGF domain for Ca 2+ more than 70-fold 0.045 ± 0.007 Chelator [10] cbEGF12-13
350 ± 40 (cb33) NMR [8] [9]. Following structure and dynamics experiments, this could be attributed to the interdomain location of the Ca 2+ -binding site in the C-terminal domain within the domain pair, and a hydrophobic packing interaction across the two domains which stabilized the structure. Measurement of Ca 2+ -binding affinities for heterologous domain pairs soon identified a wider range of affinities across fibrillin-1 than expected (Table 1) [10, 26] . In particular, it was observed that, despite having the same domain architecture, TB6-cbEGF32 had a Ca 2+ -binding dissociation constant in the millimolar range, whereas that for TB4-cbEGF23 was in the nanomolar range. The atomic structure of cbEGF22-TB4-cbEGF23 revealed a possible explanation for this, since extensive interdomain hydrophobic contacts between TB4 and cbEGF23 were observed. The role of these contacts was subsequently investigated by structure-based mutagenesis and NMR, and the extent of interface formation could be correlated directly with Ca 2+ affinity [10] . The physiological explanation for the range of Ca 2+ affinities within cbEGF domains across fibrillin-1 is unknown, but may relate to the requirement for this protein to function in a very dynamic tissue, or to the degree of flexibility required for the microfibril assembly process. From these data, it was possible to provide new constraints for fibrillin-1 organization within the microfibril, since the Ca 2+ -binding properties of TB7-cbEGF37 (K d of 45 nM) were very similar to those of TB4-cbEGF23 (K d of 16 nM). This suggested that the structural organization of the TB7 region is similar to that of TB4 and that in this section fibrillin-1 does not adopt a jackknife conformation as proposed in the microfibril model based on EM data.
Integrin αVβ3-binding properties of TB4
Fibrillin-1, in common with other modular extracellular matrix proteins, interacts with a large number of cell matrix components including cell-surface integrin receptors [24, 25] . Integrin interactions may be particularly important in tissues where microfibrils are observed in close proximity to cells such as in the elastic lamellae within the aorta and/or may play a role in microfibril assembly. The identification of the canonical integrin-binding RGD motif on the tip of a flexible loop within TB4 in the structure of cbEGF22-TB4-cbEGF23 facilitated the investigation of the structural requirements for integrin binding to this region. Initially, αVβ3 interactions were studied using a combination of cellular and molecular assays [17] . Analysis of cell attachment and spreading, performed with BHK (baby-hamster kidney) cells plated on recombinant cbEGF22-TB4 and TB4-cbEGF23 fragments, demonstrated that both domain pairs mediated equivalent cell attachment. However, only cbEGF22-TB4 was able to induce cell spreading, a marker of signalling through the integrin receptor. This was attributed to the slower dissociation of the cbEGF22-TB4-αVβ3 complex, since the experimental K d measured for this fragment using SPR (surface plasmon resonance) (K d ∼ 40 nM) was found to be ∼ 2-fold lower than that measured for TB4-cbEGF23. Although the observed differences in K d were not considerable, they were highly reproducible in independent experiments as well as alternative experimental settings, which made use of distinct immobilization procedures to study fibrillin-1-integrin interactions in reverse orientation (J. Jovanović, H. Mardon, J. Takagi and P.A. Handford, unpublished work). The relatively small difference in the stability of these complexes does, however, translate into a dramatic difference at the cellular level: fluorescent labelling of human stromal fibroblasts revealed that only cells plated on cbEGF22-TB4 had the intracellular architecture characteristic of well-spread cells with αVβ3 co-localizing with actin in focal contacts (Figure 4a ). The likely explanation for this is that, at the cell surface, ligand binding often initiates integrin clustering, leading to a highavidity multivalent interaction rather than the 1:1 interaction measured by SPR. Thus the simple presentation of each component within the SPR or ELISA experiment may not fully reflect the affinity changes occurring at a cell surface.
These data are consistent with both cbEGF22-TB4 and TB4-cbEGF23 domain pairs containing the molecular determinants necessary for the initial integrin engagement, with cbEGF22 being able to contribute a synergistic activity to TB4 which can trigger the post-attachment downstream signalling, leading to cell spreading and focal contact formation.
Domain-swap experiments demonstrate that cbEGF22 stabilizes TB4 integrinbinding conformation indirectly
Modelling of cbEGF22-TB4-cbEGF23-αVβ3 complex based on the crystal structure of the αVβ3-RGD cyclic pentapeptide indicated that cbEGF22 was in close proximity to the β3 I-like domain, raising the possibility that contacts between these two regions could modulate receptor binding [17] . Alternatively, the N-terminal linkage of cbEGF22 could act to stabilize the integrin-binding conformation of TB4. To distinguish between these two possibilities, domainswap mutants were designed in which cbEGF22 was replaced by other cbEGF modules with surface loops of the (a) An N-terminal linkage of cbEGF22 to TB4 is required for the activation of αVβ3 integrin, leading to cell spreading and focal contact formation, as demonstrated by immunocytochemical analysis of fibroblasts adherent on fibrillin-1 constructs. Actin stress fibres were stained green with phalloidin, nuclei stained blue with DAPI (4 ,6-diamidino-2-phenylindole), and αVβ3 integrin was visualized by indirect fluorescence with a Texas Red-conjugated monoclonal antibody. In stromal fibroblasts adherent on cbEGF22-TB4 and cbEGF22-TB4-cbEGF23, actin was assembled into prominent stress fibres terminating on both ends in αVβ3-rich focal contacts (orange due to the overlap of green and red fluorescence), whereas, in cells adherent on TB4-cbEGF23, actin and integrin remained mostly diffuse. Scale bar, 10 μm. (b) BHK attachment and spreading on domain-swap cbEGF23-TB4 and cbEGF24-TB4 fragments demonstrate that an N-terminal cbEGF domain modulates integrin binding indirectly, by stabilizing the integrin-binding conformation in TB4. (c) SPR analysis of recombinant α5β1 integrin binding to fibrillin-1 compared with fibronectin domain pairs indicates that α5β1 is a low-affinity receptor for fibrillin-1. When α5β1 was flown over fibrillin-1 and fibronectin domain pairs immobilized at equimolar levels via streptavidin-biotin capture, the binding observed in the flow cell with cbEGF22-TB4 was ∼30-fold lower than that in the flow cell with FIII9-10. Sensorgrams obtained with αVβ6 integrin as a control analyte, showing significantly higher levels of binding to cbEGF22-TB4, are included for comparison. (d) Non-focal contact distribution of α5β1 in VB6 keratinocytes adherent on fibrillin-1 fragments suggests that, upon engagement with fibrillin-1, this integrin may be mediating a lesser degree and/or different type of intracellular signalling from that observed with a well-established physiological ligand, fibronectin. Double labelling of VB6 cells for α5 (red) and β6 (green) integrins shows that, owing to co-localization of both integrins, focal contacts assembled on FIII9-10 appear orange. However, in cells adherent on fibrillin substrates, α5 integrin remains diffusely distributed over the entire cell surface, causing the focal contacts to appear green because of their high β6 content. Scale bar, 10 μm.
same length, thus preserving the overall conformation of the TB4-containing domain pair. Two constructs containing cbEGF23-TB4 and cbEGF24-TB4 domain pairs were made, and their adhesion activity was tested in BHK cell attachment and spreading assays (Figure 4b ). Both constructs retained attachment and spreading activity similarly to that of the native cbEGF22-TB4, indicating that cbEGF22 does not contain a specific sequence that contributes to the integrin-ligand interface, but supports integrin activation indirectly, probably through stabilization of TB4.
Binding of TB4 to α5β1 and αVβ6
Further experiments investigated the interaction of fibrillin-1 fragments with α5β1 and αVβ6 integrins [27] . VB6 keratinocytes, which express high levels of αVβ6, but no αVβ3, were found to attach and spread equally well on both cbEGF22-TB4 and TB4-cbEGF23, indicating different molecular requirements for this integrin compared with those of αVβ3. In both cases, immunocytochemistry demonstrated the focal contact localization of αVβ6, consistent with the cell attachment and spreading data. Furthermore, SPR analysis using recombinant purified αVβ6 showed this integrin to be a moderate-affinity receptor for both TB4-containing fibrillin pairs (K d ∼450 nM) [27] .
The role of α5β1 integrin in fibrillin function has been debated. Previous data suggested that, in some cell lines, this integrin functioned as a fibrillin receptor [28, 29] , but cellfree systems failed to demonstrate an interaction [17, 24] . We therefore analysed α5β1-fibrillin interaction using a combination of molecular and cellular assays [27] . In SPR experiments, only a weak binding of recombinant purified α5β1 to fibrillin domain pairs or the triple cbEGF22-TB4-cbEGF23 fragment could be observed, contrasting sharply with the high-affinity binding to the FIII9-10 control (Figure 4c ). The activity of the fibrillin fragments in this experiment was proved by obtaining the expected level of binding with αVβ6. The low affinity of the interaction precluded calculation of a dissociation constant by SPR, but, by using an ELISA-based system, we were able to estimate the apparent K d as > 1 μM. We investigated further the capacity of fibrillin ligands to activate the α5β1 receptor in a cellular context by immunofluorescence analysis of focal contacts assembled in VB6 keratinocytes plated on fibrillin fragments. Double labelling of high α5β1-and αVβ6-expressing VB6 cells for α5 and β6 subunits revealed that fibrillin-induced focal contacts had high β6 but low α5 content, whereas those assembled on fibronectin FIII9-10 control were both α5-and β6-rich (Figure 4d ). This indicated that fibrillin ligands selectively recruit β6 integrin into focal contacts, whereas the α5 receptor remains diffusely distributed over the entire cell surface, consistent with the low affinity of this interaction at the cell surface. The non-focal distribution of α5β1 was recapitulated in stromal fibroblasts despite this integrin being the major contributor to their overall adhesion to fibrillin. The variation in the α5β1-staining pattern and the notable difference in the morphology of fibrobasts adherent on fibrillin compared with fibronectin substrates, also observed by Bax et al. [28] , suggested to us that α5β1 engagement by fibrillin might elicit a different type or lesser amount of intracellular signalling compared with the high-affinity ligand fibronectin. This interpretation is, however, different to that made by Bax et al. [30] . On the basis of solid-phase adhesion assays with α5β1-and αVβ3-expressing dermal fibroblasts, they concluded that integrin α5β1 mediated strong adhesion to TB4-containing fibrillin-1 fragments, which was enhanced further by an array of N-terminal cbEGF domains [28, 30] . However, in our hands, we were unable to use adhesion assays to dissect the molecular requirements of α5β1-ligand complex formation because a cell line which expresses high levels of α5β1 integrin with no background expression of αVβ3 or αVβ6 was not available. Most cell lines express multiple integrin receptors for any given extracellular matrix ligand. Furthermore, an inherent problem of using adhesion assays with function-blocking antibodies is that specific interference with one integrin may influence the activity of other integrins on the same cell [31] . Therefore, until suitable cell lines become available, we believe a multidisciplinary approach, combining cellular with in vitro protein-protein binding assays, provides more detailed insight into the molecular mechanisms underlying fibrillin-integrin interactions.
Disease-causing mutations and their effects on TB4: structural or functional?
The identification of a specific protein-protein interaction mediated by TB4 together with the unusually high Ca 2+ affinity of the TB4-cbEGF23 fragment are suggestive of potential mechanisms whereby missense mutations affecting TB4 might exert their pathogenic effects. It is interesting to speculate that these mechanisms may be quite diverse given the structural and functional properties of the TB4 domain. Substitutions may affect either presentation of the RGD loop, resulting in reduced integrin binding or altered specificity, and/or the global fold of TB4 and its pairwise interactions with cbEGF23, reducing the affinity of this domain for Ca 2+ . Currently, five different substitutions are documented within TB4 (Figure 3 ). In addition, a naturally occurring in-frame duplication of the murine FBN1 gene exists which results in the expression of a larger fibrillin-1 polypeptide containing an additional TB4 domain [32] . This gives rise to a tight skin phenotype with cutaneous fibrosis and thickened dermis. It is interesting to speculate that the pathogenic effects of the modified fibrillin-1 might be due to altered integrin specificity, although effects on other cell-matrix interactions and the microfibril assembly process cannot be excluded. Our establishment of biophysical, biochemical and cell biological methods to assess structure and Ca 2+ -binding properties, together with our integrin binding assays, now make us well placed to investigate the molecular effects of changes to the TB4 region.
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